Hexokinase II inhibition by 3-bromopyruvate sensitizes myeloid leukemic cells K-562 to anti-leukemic drug, daunorubicin

Time dependent response of daunorubicin on cytotoxicity, cell cycle and DNA repair in acute lymphoblastic leukaemia

(2019) Hussain Mubarak Al-Aamri et al.   BMC CANCER

Glycometabolic adaptation mediates the insensitivity of drug-resistant K562/ADM leukaemia cells to adriamycin via the AKT-mTOR/c-Myc signalling pathway

(2017) Xueyan Zhang et al.   Molecular Medicine Reports

ATP Release from Chemotherapy-Treated Dying Leukemia Cells Elicits an Immune Suppressive Effect by Increasing Regulatory T Cells and Tolerogenic Dendritic Cells

(2017) Mariangela Lecciso et al.   Frontiers in Immunology

Cell intrinsic and extrinsic regulation of leukemia cell metabolism

(2016) Yajian Jiang et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

The Warburg Effect: How Does it Benefit Cancer Cells?

(2016) Maria V. Liberti et al.   TRENDS IN BIOCHEMICAL SCIENCES

Resistance to chemotherapy is associated with altered glucose metabolism in acute myeloid leukemia

(2016) KUI SONG et al.   Oncology Letters

Interactions between mitochondrial reactive oxygen species and cellular glucose metabolism

(2015) Dania C. Liemburg-Apers et al.   ARCHIVES OF TOXICOLOGY

An update of current treatments for adult acute myeloid leukemia

(2015) H. Dombret et al.   BLOOD

Transient elevation of glycolysis confers radio-resistance by facilitating DNA repair in cells

(2015) Anant Narayan Bhatt et al.   BMC CANCER

Violacein induces cell death by triggering mitochondrial membrane hyperpolarization in vitro

(2015) Angélica Maria de Sousa Leal et al.   BMC MICROBIOLOGY

The Warburg effect in tumor progression: Mitochondrial oxidative metabolism as an anti-metastasis mechanism

(2015) Jianrong Lu et al.   CANCER LETTERS

Metabolic Signature Identifies Novel Targets for Drug Resistance in Multiple Myeloma

(2015) P. Maiso et al.   CANCER RESEARCH

Metabolic control of the cell cycle

(2015) Joanna Kalucka et al.   CELL CYCLE

IMATINIB IN CHRONIC MYELOID LEUKEMIA: AN OVERVIEW

(2014) Tomasz Sacha   Mediterranean Journal of Hematology and Infectious Diseases

Association of overexpression of hexokinase II with chemoresistance in epithelial ovarian cancer

(2013) Dong Hoon Suh et al.   CLINICAL AND EXPERIMENTAL MEDICINE

Targeting VDAC-bound hexokinase II: a promising approach for concomitant anti-cancer therapy

(2013) George S Krasnov et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Emerging Metabolic Targets in the Therapy of Hematological Malignancies

(2013) Zaira Leni et al.   Biomed Research International

First-line imatinib mesylate in patients with newly diagnosed accelerated phase-chronic myeloid leukemia

(2012) D Rea et al.   LEUKEMIA

Do reactive oxygen species play a role in myeloid leukemias?

(2011) P. S. Hole et al.   BLOOD

DNA Damage Response Is Suppressed by the High Cyclin-dependent Kinase 1 Activity in Mitotic Mammalian Cells

(2011) Wei Zhang et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Targeting glycolysis in leukemia: A novel inhibitor 3-BrOP in combination with rapamycin

(2011) Lauren J. Akers et al.   LEUKEMIA RESEARCH

Imatinib resistance associated with BCR-ABL upregulation is dependent on HIF-1α-induced metabolic reprograming

(2010) F Zhao et al.   ONCOGENE

Role of mitochondria-associated hexokinase II in cancer cell death induced by 3-bromopyruvate

(2009) Zhao Chen et al.   BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS

Abnormalities in Glucose Uptake and Metabolism in Imatinib-Resistant Human BCR-ABL-Positive Cells

(2009) D. J. Kominsky et al.   CLINICAL CANCER RESEARCH

The role of cellular oxidative stress in regulating glycolysis energy metabolism in hepatoma cells

(2009) Dong-yun Shi et al.   Molecular Cancer

Inhibition of glycolysis modulates prednisolone resistance in acute lymphoblastic leukemia cells

(2008) E. Hulleman et al.   BLOOD